Mpox: What Have We Learned and How Do We Better Prepare for the Future?
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 39820687.
- Also identified by DOI 10.1093/infdis/jiaf040 and PMC identifier 12349931.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The global outbreak of clade IIb mpox in 2022-2023 changed our understanding of the epidemiology and prevention of mpox, simultaneously highlighting inequities in access to vaccines, diagnostics, and therapeutics. With the recent multinational spread of clade Ib mpox, it is important to revisit these lessons to improve future response. In September 2024, an international mpox symposium was held at Johns Hopkins University to discuss what we have learned and how to better prepare for the future. Here we highlight perspectives from that meeting and priorities for future mpox research.
Medical subject headings
- Disease Outbreaks